Latest News

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form

April 28, 2021

【財訊快報】昱厚生技新藥AD17002，申請鼻病毒引起之氣喘二期臨床試驗

Press

April 27, 2021

The Company Announces Submission of Investigator-Initiated Trial (IIT) Application to the TFDA for AD17002 in the Treatment of Rhinovirus-Induced Asthma.

Updates

April 7, 2021

【經濟日報】國光生公費流感疫苗訂單到手將積極展開國際化布局

Press

April 6, 2021

【經濟日報C6】昱厚鼻噴疫苗拚打世界盃

Press

March 29, 2021

【工商時報】接種疲乏效應國產疫苗有望打世界盃

Press